Regulation of human mesangial cell collagen expression by transforming growth factor-β1

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 3 44-3, 1998, Pages

  Poncelet, Anne Christine ^a,b   Schnaper, H William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Pediatrics W 140   (United States)

Author keywords

Collagen; Extracellular matrix; Growth factor; Kidney

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; GELATINASE A; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031658170     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.3.f458     Document Type: Article

References (42)

1. Ailenberg, M., and M. Silverman. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem. J. 313: 879-884, 1996.
2. Akagi, Y., Y. Isaka, M. Arai, T. Kaneko, M. Takenaka, T. Moriyama, Y. Kaneda, A. Ando, Y. Orita, T. Kamada, N. Ueda, and E. Imai. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 50: 148-155, 1996.
3. Border, W. A., and N. A. Noble. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int. 51: 1388-1396, 1997.
4. Border, W. A., N. A. Noble, T. Yamamoto, J. R. Harper, Y. Yamaguchi, M. D. Pierschbacher, and E. Ruoslahti. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992.
5. Border, W. A., S. Okuda, L. R. Languino, and E. Ruoslahti. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int. 37: 689-695, 1990.
6. Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. Suppression of experimental glomerulonephritis by anti serum against transforming growth factor β1. Nature 346: 371-374, 1990.
7. Buyukbabani, N., and D. Droz. Distribution of the extracellular matrix components in human glomerular lesions. J. Pathol. 172: 199-207, 1994.
8. Carmichael, D. F., A. Sommer, R. C. Thompson, D. C. Anderson, C. G. Smith, H. G. Welgus, and G. P. Stricklin. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc. Natl. Acad. Sci. USA 83: 2407-2411, 1986.
9. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. Chu, M.-L., J. C. Myers, M. P. Bernard, J.-F. Ding, and F. Ramirez. Cloning and characterization of five overlapping cDNAs specific for the human proα1(I) collagen chain. Nucleic Acids Res. 10: 5925-5934, 1982.
11. Collier, I. E., S. M. Wilhelm, A. Z. Eisen, B. L. Marmer, G. A. Grant, J. L. Seltzer, A. Kronberger, C. He, E. A. Bauer, and G. I. Goldberg. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263: 6579-6587, 1988.
12. Daphna-Iken, D., and A. R. Morrison. Interleukin-1β induces interstitial collagenase gene expression and protein secretion in renal mesangial cells. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F831-F837, 1995.
13. Davies, M., G. J. Thomas, J. Martin, and D. H. Lovett. The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells. Biochem. J. 251: 419-425, 1988.
14. Grande, J. P. Role of transforming growth factor-β in tissue injury and repair. Exp. Biol. Med. 214: 27-40, 1997.
15. Grinnell, F., H. Fukamizu, P. Pawelek, and S. Nakagawa. Collagen processing, crosslinking, and fibril bundle assembly in matrix produced by fibroblasts in long-term cultures supplemented with ascorbic acid. Proc. Soc. Exp. Cell Res. 181: 483-491, 1989.
16. Haberstroh, U., G. Zahner, M. Disser, F. Thaiss, G. Wolf, and R. A. K. Stahl. TGF-β stimulates rat mesangial cell proliferation in culture: role of PDGF β-receptor expression. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F199-F205, 1993.
17. Hansch, G. M., C. Wagner, A. Burger, W. Dong, G. Staehler, and M. Stoek. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor β (TGFβ) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J. Cell. Physiol. 163: 451-457, 1995.
18. Hitomi, K., and N. Tsukagoshi. Role of ascorbic acid in modulation of gene expression. In: Sub-Cellular Biochemistry, edited by J. R. Harris. New York: Plenum, 1996, vol. 25, p. 41-56.
19. Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92: 2597-2601, 1993.
20. Kleiner, D. E., and W. G. Stetler-Stevenson. Structural biochemistry and activation of matrix metalloproteinases. Curr. Opin. Cell Biol. 5: 891-897, 1993.
21. Marti, H. P., L. Lee, M. Kashgarian, and D. H. Lovett. Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am. J. Pathol. 144: 82-94, 1994.
22. McKay, N. G., T. F. Khong, N. E. Haites, and D. A. Power. The effect of transforming growth factor β1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing. Exp. Mol. Pathol. 59: 211-224, 1993.
23. McKay, N. G., L. J. Striker, J. W. Stauffer, T. Doi, L. Y. Agodoa, and G. E. Striker. Transforming growth factor β: murine glomerular receptors and responses of isolated glomerular cells. J. Clin. Invest. 83: 1160-1167, 1989.
24. Megyesi, J., J. Di Mari, N. Udvarhelyi, P. M. Price, and R. Safirstein. DNA synthesis is dissociated from immediate-early gene response in the post-ischemic kidney. Kidney Int. 48: 1451-1458, 1995.
25. Niemir, Z. I., H. Stein, I. L. Noronha, C. Kruger, K. Andrassy, E. Ritz, and R. Waldherr. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int. 48: 1530-1541, 1995.
26. Okuda, S., L. R. Languino, E. Ruoslahti, and W. A. Border. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J. Clin. Invest. 86: 453-462, 1990.
27. Padh, H. Cellular functions of ascorbic acid. Biochem. Cell Biol. 68: 1166-1173, 1990.
28. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994.
29. Schnaper, H. W. Focal segmental glomerulosclerosis. In: Immunologic Renal Disease, edited by E. G. Neilson and W. Couser. New York: Lippincott-Raven, 1997, p. 1003-1026.
30. Schnaper, H. W., J. B. Kopp, A. C. Poncelet, S. C. Hubchak, W. G. Stetler-Stevenson, P. E. Klotman, and H. K. Kleinman. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J. Cell Sci. 109: 2521-2528, 1996.
31. Schnaper, H. W., and A. M. Robson. Nephrotic syndrome: minimal change disease, focal glomerulosclerosis and related disorders. In: Diseases of the Kidney (6th ed.), edited by R. W. Schrier and C. W. Gottschalk. Boston: Little, Brown, 1996, p. 1725-1780.
32. Shetty, S., A. Kumar, and S. Idell. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17: 1075-1083, 1997.
33. Smyth, Templeton N., P. D. Brown, A. T. Levy, I. M. K. Marulies, L. A. Liotta, and W. G. Stetler-Stevenson. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res. 50: 5431-5437, 1990.
34. Stetler-Stevenson, W. G., P. D. Brown, M. Onisto, A. T. Levy, and L. A. Liotta. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265: 13933-13938, 1990.
35. Suzuki, S., I. Ebihara, Y. Tomino, and H. Koide. Transcriptional activation of matrix genes by transforming growth factor β1 in mesangial cell. Exp. Nephrol. 1: 229-237, 1993.
36. Tomooka, S., W. A. Border, B. C. Marshall, and N. A. Noble. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42: 1462-1469, 1992.
37. Turck, J., A. S. Pollock, L. K. Lee, H.-P. Marti, D. H. Lovett. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J. Biol. Chem. 271: 15074-15083, 1996.
38. Wilson, H. M., F. J. Reid, P. A. Brown, D. A. Power, N. E. Haites, and N. A. Booth. Effect of transforming growth factor-β1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells. Exp. Nephrol. 1: 343-350, 1993.
39. Wolthuis, A., A. Boes, and J. Grond. Cell density modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells. Am. J. Pathol. 143: 1209-1219, 1993.
40. Yamamoto, T., T. Nakamura, N. A. Noble, E. Ruoslahti, and W. A. Border. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90: 1814-1818, 1993.
41. Yamamoto, T., N. A. Noble, A. H. Cohen, C. C. Nast, A. Hishida, L. I. Gold, and W. A. Border. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 49: 461-469, 1996.
42. Yoshioka, K., T. Takemura, K. Murakami, M. Okada, S. Hino, H. Miyamoto, and S. Maki. Transforming growth factor-β: protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 68: 154-163, 1993.